Drug Manufacturing

Nov 16, 2017
By Pharmaceutical Technology Editors
Bayer will make a $400-million upfront payment to develop and commercialize two anti-cancer compounds in Loxo Oncology’s portfolio.
Nov 16, 2017
By Pharmaceutical Technology Editors
As part of the deal, J&J’s Janssen will pay an upfront payment of $50 million to research, develop, and commercialize up to six bispecific antibodies.
Nov 16, 2017
By Pharmaceutical Technology Editors
Germany tops quality ranking in the inaugural CPhI Global Pharma Index.
Nov 15, 2017
Pharmaceutical Technology
The use of approved platform technologies can reduce the time and cost required to generate new vaccines.
Nov 15, 2017
Pharmaceutical Technology
A new facility type integrates next-generation mobile cleanroom systems.
Nov 15, 2017
Pharmaceutical Technology
The use of therapeutic vaccines presents a new way to manage diseases, such as cancer and sexually transmitted diseases.
Nov 15, 2017
Equipment and Processing Report
Optimizing water and HVAC systems can reduce resource use in all pharma facilities, and, for biopharma manufacturing, the supply chain of consumables should be evaluated.
Nov 13, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Alcami will manufacture clinical supply of the API for a drug candidate targeting various hematologics and solid cancers.
Nov 13, 2017
By Pharmaceutical Technology Editors
The companies have established a joint laboratory to develop full continuous processing to manufacture high yields of monoclonal antibodies at reduced costs.
Nov 10, 2017
By Pharmaceutical Technology Editors
As part of Recipharm’s ongoing initiative to improve profitability and competitiveness, a decision has been made to end operations in Stockholm and Höganäs.
native1_300x100
lorem ipsum